Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02239861Phase 1Completed
TAA-Specific CTLS for Solid Tumors (TACTASOM)
Rhabdomyosarcoma
PrincipalinvestigatorStart date: 2015-04-01
NCT01953900Phase 1Active Not Recruiting
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
NeuroblastomaOsteosarcoma
PrincipalinvestigatorStart date: 2014-04-01

Research Network

Collaboration Network

12 collaborators·14 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Baylor College of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Moderately Similar
19 trials

Shared therapeutic areas:

NeuroblastomaOsteosarcomaRhabdomyosarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Giselle Sholler, MD

Beat Childhood Cancer at Atrium Health

Moderately Similar
10 trials

Shared therapeutic areas:

NeuroblastomaOsteosarcomaRhabdomyosarcoma
Similarity Score30%

Kenneth G. Lucas, MD

Milton S. Hershey Medical Center

Moderately Similar
8 trials

Shared therapeutic areas:

NeuroblastomaOsteosarcomaRhabdomyosarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Michael B Gill

Power Life Sciences Inc.

Moderately Similar
105 trials

Shared therapeutic areas:

NeuroblastomaOsteosarcomaRhabdomyosarcoma
Similarity Score30%

Lisa L Wang, MD

Baylor College of Medicine

Related
1 trials

Shared therapeutic areas:

NeuroblastomaOsteosarcoma

Worked with same sponsors:

Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine+2 more
Collaborated on 1 trial
Similarity Score24%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

NeuroblastomaRhabdomyosarcoma

Worked with same sponsors:

Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine+3 more
Collaborated on 1 trial
Similarity Score24%

Mia Weiss, M.D.

Washington University School of Medicine

Related
5 trials

Shared therapeutic areas:

NeuroblastomaRhabdomyosarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Emily Slotkin, MD

Memorial Sloan Kettering Cancer Center

Related
8 trials

Shared therapeutic areas:

OsteosarcomaRhabdomyosarcoma
Similarity Score20%

Sarah Whittle, MD

Baylor College of Medicine

Related
1 trials

Shared therapeutic areas:

Rhabdomyosarcoma

Worked with same sponsors:

Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine+3 more
Collaborated on 1 trial
Similarity Score14%

Ann Leen, PhD

Baylor College of Medicine

Related
1 trials

Shared therapeutic areas:

Rhabdomyosarcoma

Worked with same sponsors:

Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine+3 more
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02239861Phase 1PrincipalInvestigator

TAA-Specific CTLS for Solid Tumors (TACTASOM)

Rhabdomyosarcoma
Completed
NCT01953900Phase 1PrincipalInvestigator

iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma

NeuroblastomaOsteosarcoma
Active Not Recruiting

All 2 trials loaded